Patents Assigned to Reinnervate Limited
  • Retinoid compounds and their use
    Patent number: 8293803
    Abstract: The invention relates to retinoid compounds of the formula (I): wherein V is a hydrophobic group; W is a non-polyenic linker; and X is a polar group comprising a hydrogen bond donor; or a salt thereof, and to the use of such compounds in the control of cell differentiation.
    Type: Grant
    Filed: August 28, 2007
    Date of Patent: October 23, 2012
    Assignee: Reinnervate Limited
    Inventors: Stefan Przyborski, Andrew Whiting, Todd Marder